skip to primary navigationskip to content

Search results 28 items matching your search terms.

Did you not find what you were looking for? Try the Advanced Search to refine your search.

Subscribe to an always-updated feed of these search terms

A versatile drug delivery system targeting senescent cells
Personalised Breast Cancer DNA ‘barcoding’ Programme to be rolled out
Highly sensitive blood test detects early stage breast cancer
Researchers collaborate on new drug combinations for melanoma
Oncology leaders in top 50 female innovators in UK healthcare business
Harrassment, Bullying and Sexual Misconduct - Breaking the Silence
Genetic study provides the most comprehensive map to date of breast cancer risk
Mapping breast cancer cell by cell
Early diagnosis prize
Professor Anna Philpott receives the '2018 Anne McLaren Outstanding Women in Developmental Biology Award'
£226 million UK investment in cancer research announced
Cambridge in top 20 cancer centres in Europe
Predicting cancer risk through studying mutations in blood
New findings shed light on treating advanced breast cancer
£5.6M boost for children’s brain tumour research
Halving treatment for HER2+ early breast cancer patients
Revised clinical guidelines for treating cancer patients during COVID-19 pandemic
LinkedIn Learning at Cambridge Hub
Mapping oesophageal cancer genes leads to new drug targets
Clinical trial launches to develop breath test for multiple cancers
Clinical trial offers experimental cancer treatment to patients with the same genetic mutations
Cambridge Cancer Centre Designated as a Major Cancer Centre by Cancer Research UK
26 June 2015
Congratulations to Anna Philpott on her appointment to a University Professorship
June 2015
School of Clinical Medicine Mental Health Awareness Programme
Charlotte Coles appointed as new Deputy Head of Department
Jamie Blundell named as UKRI Future Leaders Fellow
International Alliance for Cancer Early Detection
CRUK invests £56 million to set up a UK network of excellence in radiation research